Markets
Tendies
@tendies
Bought INBS
Shares
0.0%
At 1.44, Now 1.44
I'm really bullish on INBS right now. With FDA submission just around the corner and a strong market for their innovative drug testing technology, I b...
Read
More
Thesis
I'm really bullish on INBS right now. With FDA submission just around the corner and a strong market for their innovative drug testing technology, I believe this stock can soar. The potential is huge, especially after they get FDA clearance and expand in the U.S. market.
Go back
Tendies
@tendies
Bought INBS
Shares
up 14.09%
At 1.49, Exited 1.7
I just bought shares of INBS because with their FDA submission coming soon and solid financials, I believe the stock is significantly undervalued. The...
Read
More
Thesis
I just bought shares of INBS because with their FDA submission coming soon and solid financials, I believe the stock is significantly undervalued. The patented fingerprint drug test is a game changer, and I expect a big price pop when the news drops and growth to continue afterward.
Go back
Tendies
@tendies
Bought INBS
Shares
up 8.74%
At 2.06, Exited 2.24
I'm bullish on INBS as its non-invasive drug testing technology is gaining traction, especially with FDA approval coming soon. The stock just saw sign...
Read
More
Thesis
I'm bullish on INBS as its non-invasive drug testing technology is gaining traction, especially with FDA approval coming soon. The stock just saw significant volume and breakout potential around the 50 DMA, so I'm looking for a solid upside as it enters the US market.
Go back
Tendies
@tendies
Bought INBS
Shares
up 8.74%
At 2.06, Exited 2.24
I just saw INBS closed at $1.58 with great volume and potential FDA approval on the horizon. The upcoming 10-Q is expected to show a revenue spike, an...
Read
More
Thesis
I just saw INBS closed at $1.58 with great volume and potential FDA approval on the horizon. The upcoming 10-Q is expected to show a revenue spike, and with the market cap under $5 million, I'm convinced this could have a strong week ahead.
Go back
